BioNTech Investor Day Presentation Deck slide image

BioNTech Investor Day Presentation Deck

High-quality vaccine manufacturing is our priority Approved suppliers to provide raw materials Transfer of know- how and trained personnel to build manufacturing capabilities in a sustainable and safe way 280 components from 86 suppliers in 19 countries 50,000 steps from beginning of a Pfizer-BioNTech COVID-19 vaccine batch to bulk filling Note: Figures refer to the Pfizer-BioNTech COVID-19 vaccine and are exemplary. Local quality control on site to ensure the safety and quality of the production process 40 individual quality control tests for each finished vaccine batch BIONTECH Global support by quality control center in Marburg to support the operations of all BioNTainers 24/7 support and monitoring of processes
View entire presentation